Adhesion molecules as targets for the treatment of neoplastic diseases

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Current cancer treatments like chemotherapy and radiotherapy have low therapeutic indices, damaging healthy tissues and leading to static cure rates.
• Neoplastic cell specificity is crucial for effective cancer treatment, necessitating alternative therapeutic strategies.
• Abnormal cell-adhesion molecule expression is common in malignancies and linked to invasion and metastasis.

Purpose of the Study:

• To explore the potential of targeting anti-adhesion molecules as a novel therapeutic strategy for neoplastic diseases.
• To evaluate anti-adhesion molecules as candidates for targeted cancer therapies due to their role in tumorigenesis.

Main Methods:

• This review analyzes the role of cell-cell and cell-matrix adhesion in tumorigenesis, invasion, and metastasis.
• It examines the expression patterns of adhesion molecules in various malignancies.
• The review discusses the therapeutic potential of targeting these molecules.

Main Results:

• Reduced cell-cell and cell-matrix adhesion are early events in tumorigenesis, implicated in cancer spread.
• Abnormal adhesive marker expression is a common feature across most malignancies.
• These molecules are present throughout neoplastic development, from early to late stages.

Conclusions:

• Targeting anti-adhesion molecules presents a promising strategy for developing specific antineoplastic therapies.
• This approach holds potential for improving cancer treatment by selectively eliminating cancer cells.
• Further research into anti-adhesion molecule targeting could lead to more effective cancer interventions.